This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
the study design was not provided.
Analysis of effectiveness
The analysis of the clinical study was conducted on an intention to treat basis. The outcome measure was the caregivers' quality of life, which was assessed using the EuroQol five-dimensional questionnaire (EQ-5D). Caregivers responded to the EQ-5D at baseline and at 4, 12, 26 and 52 weeks after the stroke. Missing values were imputed only for caregivers with partial missing data. However, no imputation was carried out if data were missing at all assessment points, if no caregiver data were available from the week 4 assessment onwards, or if the patient had died before the caregiver's missing assessment. Utility weights from a UK general population survey were applied to EQ-5D health states to calculate the quality-adjusted life-years (QALYs). In additional, the length of stay in stroke units for patients with trained caregivers versus patients with no trained caregivers was provided. There was no information on the comparability of the study groups.
Effectiveness results
At baseline, the mean QALYs were 0.94 (+/-0.10) in the training group and 0.94 (+/-0.14) in the control group.
After one year, the mean QALYs were 0.91 (+/-0.11) in the training group and 0.90 (+/-0.14) in the control group.
There was no statistically significant difference between the groups in QALY losses between baseline and one year.
Patients in the training group stayed in hospital less than patients in the no training group. The mean stay was 30.8 days for the training group patients versus 43.2 days for the no training group patients (mean difference -12.4 days, 95% confidence interval, CI: -19.5 --5.6).
Clinical conclusions
The effectiveness analysis showed that both groups showed a small, but comparable, reduction in QALYs. The patients in the training group were associated with a shorter hospital length of stay.
Measure of benefits used in the economic analysis
No summary benefit measure was used in the economic analysis because the effectiveness study showed there was no statistically significant difference in the reduction of QALYs. In effect, a cost-minimisation analysis was performed.
Direct costs
Discounting was not relevant since the costs were incurred during one year. The unit costs were presented separately for all cost items and a detailed breakdown of the costs was provided. The health services included in the economic evaluation were grouped as follows:
initial admission for stroke (stroke unit, physiotherapist, occupational therapist, hospital speech and language therapist); other secondary care services (general medical ward, outpatient visits, accident and emergency visit, and day hospital); social services (personal care, domestic assistance, laundry assistance, shopping assistance, meals on wheels, carelink, and social services day care centre); and community-based care (general practitioner home visit and surgery visit, district nurse, dentist, optician, chiropody home and clinic visit, and respite care).
The perspective of the health service provider (the National Health Service, NHS) was adopted in the analysis of the direct costs. Resource use was estimated using individualised data coming from the sample of patients included in the effectiveness study. Resource use after hospital discharge was estimated using a specially adapted version of the client service receipt inventory. Hospital data were available for the 3 months before stroke. The costs came from several Training caregivers reduced the costs of health care and social care in the first year after stroke compared with no training. Since the costs of informal care were comparable between training and standard care, there was no evidence of a shift in the burden of care from statutory services towards carers. The caregivers' quality of life did not change over the study period.
CRD COMMENTARY -Selection of comparators
The selection of the comparator was appropriate as it reflected conventional care at the authors' setting. You should decide whether this is a valid comparator in your own setting.
Validity of estimate of measure of effectiveness
There was limited information on the design and sample of patients since the clinical study had been published elsewhere. However, the design of the study (randomised, clinical trial) and the use of intention to treat as the basis of the clinical study ensured a high internal validity. The length of follow-up appears to have been adequate for capturing the effect of the intervention.
Validity of estimate of measure of benefit
No summary benefit measure was used in the analysis because a cost-minimisation analysis was conducted. Please refer to the comments in the "Validity of estimate of measure of effectiveness" field (above).
